Nivolumab dose selection: challenges, opportunities and lessons learned for cancer immunotherapy
Crossref DOI link: https://doi.org/10.1186/2051-1426-3-S2-P141
Published Online: 2015-11-04
Published Print: 2015-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Agrawal, Shruti
Feng, Yan
Roy, Amit
Kollia, Georgia
Lestini, Brian
Article History
First Online: 4 November 2015